Clinical psychopharmacology of eating disorders: a research update
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The paper presents a critical review (with search date 2010) of the major psychotropic medications assessed in eating disorders, namely antipsychotics, antidepressants, mood-stabilizing medications, anxiolytic and other agents. The evidence of efficacy of drug treatments is mostly weak or moderate. In addition, attrition rates are usually higher than for psychotherapies. However, there is support for use of antidepressants, particularly high-dose fluoxetine in bulimia nervosa, and anticonvulsants (topiramate) for binge-eating disorder. Low-dose antipsychotic medication may be clinically useful as adjunct treatment in acute anorexia, particularly where there is high anxiety and obsessive eating-related ruminations and failure to engage, but more trials are needed. Drug therapies such as topiramate and anti-obesity medication may aid weight loss in obese or overweight patients with binge-eating disorder; however, common or potentially serious adverse effects limit their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication
Hudson, J. I., Hiripi, E., Pope, H. G., & Kessler, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.040 · Cited by 4,973
Comorbidity of Anxiety Disorders With Anorexia and Bulimia Nervosa
Kaye, W. H., Bulik, C. M., Thornton, L., Barbarich, N., Masters, K., & the Price Foundation Collaborative Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2215 · Cited by 1,162 · cited 1×
“1998, 2005) and concurrent depressive and obsessional psychopathology (Godart et al. 2007; Kaye et al. 2004) have suggested a role for antidepressant treatment.”
BackgroundEffect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943 · cited 1×
“More importantly, safety issues related to increased cardiovascular events in obese people with high cardiovascular risk have been reported (James et al. 2010) and in 2010 sibutramine was withdrawn from the market in the USA, Europe and other countries.”
BackgroundMeta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Rosenthal, N. R., Karim, M. R., Kamin, M., & Hudson, J. I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.255 · Cited by 484
Anorexia nervosa treatment: A systematic review of randomized controlled trials
Bulik, C. M., Berkman, N. D., Brownley, K. A., Sedway, J. A., & Lohr, K. N. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20367 · Cited by 427
Anorexia Nervosa and Major Depression: Shared Genetic and Environmental Risk Factors
Wade, T. D., Bulik, C. M., Neale, M., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.469 · Cited by 375 · cited 1×
“In anorexia nervosa shared inheritance with depression (Strober et al. 2000; Wade et al. 2000), neurobiological, most notably serotonin dysfunction (Kaye et al.”
Background(1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820020059008 · Cited by 371
Binge eating disorder treatment: a systematic review of randomized controlled trials
Brownley, K. A., Berkman, N. D., Sedway, J. A., Lohr, K. N., & Bulik, C. M. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20370 · Cited by 346
Vocks, S., Tuschen‐Caffier, B., Pietrowsky, R., Rustenbach, S. J., Kersting, A., & Herpertz, S. (2010) · International Journal of Eating Disorders · doi:10.1002/eat.20696 · Cited by 343 · cited 1×
“A recent meta-analysis of comparative effect sizes for treatments of BED combined results of 38 studies of RCTs and uncontrolled studies and pooled all types of pharmacotherapy, as well as psychotherapies in computing comparative effect sizes (Vocks et al. 2010).”
Cited by
Hay, P., Chinn, D., Forbes, D., Madden, S., Newton, R., Sugenor, L., Touyz, S., & Ward, W. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414555814 · Cited by 656
Self-citationMedical complications of anorexia nervosa and bulimia
Westmoreland, P., Krantz, M. J., & Mehler, P. S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.06.031 · Cited by 467
Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder
Hilbert, A., Petroff, D., Herpertz, S., Pietrowsky, R., Tuschen-Caffier, B., Vocks, S., & Schmidt, R. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000358 · Cited by 283
Treasure, J., Zipfel, S., Micali, N., Wade, T., Stice, E., Claudino, A., Schmidt, U., Frank, G. K., Bulik, C. M., & Wentz, E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.74 · Cited by 285
Self-citation(2015) · PubMed · Cited by 93
Metadata
- Authors
- Hay, P. J., & Claudino, A. M.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-25
- Volume
- 15
- Issue
- 02
- Pages
- 209-222
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2089441523
- Cited by
- 128
- References
- 19
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical psychopharmacology of eating disorders: a research update. https://app.cochat.ai/papers/10.1017/s1461145711000460
- The paper
- Hay, P. J., & Claudino, A. M. (2012). Clinical psychopharmacology of eating disorders: a research update. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145711000460
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.